99 related articles for article (PubMed ID: 19099450)
1. Camptothecins: a SAR/QSAR study.
Verma RP; Hansch C
Chem Rev; 2009 Jan; 109(1):213-35. PubMed ID: 19099450
[No Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of 10,11-methylenedioxy-14-azacamptothecin.
Elban MA; Sun W; Eisenhauer BM; Gao R; Hecht SM
Org Lett; 2006 Aug; 8(16):3513-6. PubMed ID: 16869648
[TBL] [Abstract][Full Text] [Related]
3. Effect of E-ring modifications in camptothecin on topoisomerase I inhibition: a quantum mechanics treatment.
Xiao X; Cushman M
J Org Chem; 2005 Nov; 70(23):9584-7. PubMed ID: 16268636
[TBL] [Abstract][Full Text] [Related]
4. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
Jung LL; Zamboni WC
Drug Resist Updat; 2001 Aug; 4(4):273-88. PubMed ID: 11998845
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic activity of new 9-substituted camptothecins.
Dallavalle S; Rocchetta DG; Musso L; Merlini L; Morini G; Penco S; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 May; 18(9):2781-7. PubMed ID: 18434153
[TBL] [Abstract][Full Text] [Related]
6. 7- and 10-substituted camptothecins: dependence of topoisomerase I-DNA cleavable complex formation and stability on the 7- and 10-substituents.
Vladu B; Woynarowski JM; Manikumar G; Wani MC; Wall ME; Von Hoff DD; Wadkins RM
Mol Pharmacol; 2000 Feb; 57(2):243-51. PubMed ID: 10648633
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis of camptothecin glycosides by phase transfer-catalysis and its inhibitory activity against topo I].
Li QY; Zhang Y; Yao LP; Fu YJ; Zu YG; Chen XQ; Zheng CY
Yao Xue Xue Bao; 2005 Dec; 40(12):1116-21. PubMed ID: 16496676
[TBL] [Abstract][Full Text] [Related]
8. [Current status of camptothecin derivatives as natural antitumor agents].
Pan XD; Wang CY
Yao Xue Xue Bao; 2003 Sep; 38(9):715-20. PubMed ID: 14730926
[No Abstract] [Full Text] [Related]
9. Role of flexibility and long range communication on the function of human topoisomerase I.
Chillemi G; Fiorani P; Bruselles A; Castelli S; Campagna A; Sarra O; Tesauro C; Fiorentini M; Vassallo O; D'Annessa I; Santoleri S; Desideri A
Ital J Biochem; 2007 Jun; 56(2):110-4. PubMed ID: 17722651
[TBL] [Abstract][Full Text] [Related]
10. Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin.
Li M; Tang W; Zeng F; Lou L; You T
Bioorg Med Chem Lett; 2008 Dec; 18(24):6441-3. PubMed ID: 18986807
[TBL] [Abstract][Full Text] [Related]
11. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
Garcia-Carbonero R; Supko JG
Clin Cancer Res; 2002 Mar; 8(3):641-61. PubMed ID: 11895891
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-tumor activity of alkenyl camptothecin esters.
Cao ZS; Mendoza J; Dejesus A; Giovanella B
Acta Pharmacol Sin; 2005 Feb; 26(2):235-41. PubMed ID: 15663905
[TBL] [Abstract][Full Text] [Related]
13. A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy.
Cragg GM; Newman DJ
J Nat Prod; 2004 Feb; 67(2):232-44. PubMed ID: 14987065
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of DNA topoisomerases].
Andoh T
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1526-35. PubMed ID: 9309151
[TBL] [Abstract][Full Text] [Related]
15. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
Jung LL; Zamboni WC
Drug Resist Updat; 2001 Jun; 4(3):152-67. PubMed ID: 11768329
[TBL] [Abstract][Full Text] [Related]
16. 20-(S)-camptothecin analogues as DNA topoisomerase I inhibitors: a QSAR study.
Hansch C; Verma RP
ChemMedChem; 2007 Dec; 2(12):1807-13. PubMed ID: 17886246
[TBL] [Abstract][Full Text] [Related]
17. Persistence of camptothecin analog-topoisomerase I-DNA ternary complexes: a molecular dynamics study.
Siu FM; Che CM
J Am Chem Soc; 2008 Dec; 130(52):17928-37. PubMed ID: 19035632
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic and antiprotozoal activity of flavonoids from Lonchocarpus spp.
Borges-Argáez R; Balnbury L; Flowers A; Giménez-Turba A; Ruiz G; Waterman PG; Peña-Rodríguez LM
Phytomedicine; 2007 Aug; 14(7-8):530-3. PubMed ID: 17291734
[TBL] [Abstract][Full Text] [Related]
19. Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins.
Samorì C; Guerrini A; Varchi G; Fontana G; Bombardelli E; Tinelli S; Beretta GL; Basili S; Moro S; Zunino F; Battaglia A
J Med Chem; 2009 Feb; 52(4):1029-39. PubMed ID: 19530720
[TBL] [Abstract][Full Text] [Related]
20. Understanding topoisomerase I and II in terms of QSAR.
Verma RP
Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
